Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-01 | Future report Set alerts | |
Q2 2022 | 2022-08-08 | 0.18 | 0.18 |
Q1 2022 | 2022-05-03 | 0.19 | 0.19 |
Q4 2021 | 2022-02-09 | 0.22 | 0.22 |
Q3 2021 | 2021-11-03 | 0.23 | 0.23 |
Q2 2021 | 2021-07-28 | 0.19 | 0.19 |
Q1 2021 | 2021-05-05 | 0.17 | 0.17 |
Q4 2020 | 2021-02-10 | 0.21 | 0.21 |
Q3 2020 | 2020-11-04 | 0.00 | 0.00 |
Q2 2020 | 2020-07-29 | 0.13 | 0.01 |
2016-05-14 | Reiterated Rating | Imperial Capital | Outperform | $15.00 |
2016-05-04 | Lower Price Target | Needham & Company LLC | Buy | $15.00 to $14.00 |
2016-02-08 | Lower Price Target | Imperial Capital | Outperform | $18.00 to $15.00 |
2016-02-04 | Lower Price Target | DA Davidson | Buy | $16.00 |
2016-02-04 | Lower Price Target | Barclays | Overweight | $18.00 to $16.00 |
2016-02-04 | Lower Price Target | Buckingham Research | Neutral | $15.00 to $14.00 |
2016-02-04 | Lower Price Target | Needham & Company LLC | Buy | $18.00 to $15.00 |
2016-02-04 | Lower Price Target | Barclays PLC | Overweight | $18.00 to $16.00 |
2016-02-03 | Downgrade | Dougherty & Co | Buy to Neutral | |
2015-11-02 | Lower Price Target | RBC Capital | Sector Perform | $20.00 to $19.00 |
2015-11-02 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $20.00 to $19.00 |
2015-10-08 | Lower Price Target | Imperial Capital | Outperform | $25.00 to $18.00 |
2015-10-07 | Lower Price Target | Barclays | Overweight | $23.00 to $18.00 |
2015-10-07 | Downgrade | Buckingham Research | Buy to Neutral | $13.00 |
2015-10-07 | Lower Price Target | Needham & Company LLC | Buy | $24.00 to $18.00 |
2015-10-07 | Lower Price Target | Dougherty & Co | Buy | $26.00 to $17.00 |
2015-10-06 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2015-10-06 | Downgrade | Oppenheimer | Outperform to Market Perform | $23.00 |
2015-10-06 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2015-10-06 | Downgrade | Oppenheimer Holdings Inc. | Outperform to Market Perform | $23.00 |
2015-07-29 | Lower Price Target | Barclays | Overweight | $26.00 to $23.00 |
2015-07-29 | Lower Price Target | Needham & Company LLC | Buy | $28.00 to $24.00 |
2015-07-29 | Lower Price Target | Imperial Capital | Outperform | $28.50 to $25.00 |
2015-07-29 | Downgrade | RBC Capital | Outperform to Sector Perform | $29.00 to $20.00 |
2015-05-01 | Boost Price Target | Barclays | Overweight | $25.00 to $26.00 |
2015-05-01 | Boost Price Target | Needham & Company LLC | Buy | $26.00 to $28.00 |
2015-02-11 | Set Price Target | Oppenheimer | Buy | $24.00 |
2015-01-29 | Boost Price Target | Imperial Capital | $24.00 to $25.00 | |
2015-01-29 | Lower Price Target | Dougherty & Co | Buy | $28.00 to $26.00 |
2015-01-29 | Reiterated Rating | Needham & Company LLC | Buy | |
2015-01-13 | Upgrade | RBC Capital | Sector Perform to Outperform | $19.00 to $26.00 |
2015-01-12 | Boost Price Target | Barclays | Overweight | $22.00 to $24.00 |
2015-01-12 | Upgrade | Buckingham Research | Neutral to Buy | $21.00 to $26.00 |
2015-01-06 | Set Price Target | Needham & Company LLC | Buy | $26.00 |
2015-01-05 | Upgrade | Oppenheimer | Market Perform to Outperform | $26.00 |
2014-10-29 | Reiterated Rating | DA Davidson | Buy | $21.00 to $25.00 |
2014-10-29 | Boost Price Target | Imperial Capital | Outperform | $22.00 to $24.00 |
2014-09-17 | Initiated Coverage | DA Davidson | Buy | $21.00 |
2014-07-10 | Initiated Coverage | Dougherty & Co | Buy | $21.00 |
2014-06-19 | Initiated Coverage | Buckingham Research | Neutral | |
2014-02-27 | Initiated Coverage | Wedbush | Outperform | |
2014-01-29 | Downgrade | Oppenheimer | Outperform to Market Perform | $16.00 |
2014-01-07 | Boost Price Target | Imperial Capital | Outperform | $20.00 to $22.00 |
2014-01-07 | Boost Price Target | Maxim Group | Buy | $20.00 to $22.00 |
2013-12-11 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | $20.00 to $22.00 |
2013-12-11 | Upgrade | Wells Fargo | Market Perform to Outperform | $20.00 to $22.00 |
2013-11-25 | Boost Price Target | Maxim Group | Buy | $18.00 to $20.00 |
2013-11-21 | Initiated Coverage | Imperial Capital | Outperform | $20.00 |
2013-11-18 | Upgrade | Needham & Company LLC | Hold to Buy | $21.00 |
2013-04-25 | Reiterated | Maxim Group | Buy | $21 to $18 |
2013-04-05 | Reiterated | Maxim Group | Buy | $42 to $35 |
2012-09-21 | Initiated | Needham | Buy | $45 |
2012-07-27 | Reiterated | Maxim Group | Buy | $44 to $37 |
2012-06-28 | Reiterated | Oppenheimer | Outperform | $42 to $45 |
2012-05-02 | Reiterated | Maxim Group | Buy | $40 to $44 |
2012-03-29 | Reiterated | Oppenheimer | Outperform | $36 to $40 |
2016-05-14 | Reiterated Rating | Imperial Capital | Outperform | $15.00 |
2016-05-04 | Lower Price Target | Needham & Company LLC | Buy | $15.00 to $14.00 |
2016-02-08 | Lower Price Target | Imperial Capital | Outperform | $18.00 to $15.00 |
2016-02-04 | Lower Price Target | DA Davidson | Buy | $16.00 |
2016-02-04 | Lower Price Target | Barclays | Overweight | $18.00 to $16.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RDWR 101 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
RIMA SENVEST MANAGEMENT, L.L.C. | 3.89M |
Artisan Partners Limited Partnership | 3.01M |
LEGAL & GENERAL GROUP PLC | 2.54M |
MORGAN STANLEY | 2.02M |
RENAISSANCE TECHNOLOGIES LLC | 1.74M |
ACADIAN ASSET MANAGEMENT LLC | 1.65M |
FIRST TRUST ADVISORS LP | 1.51M |
Ion Asset Management Ltd. | 1.35M |
Delek Group, Ltd. | 1.34M |
BlackRock Inc. | 1.16M |
Neuberger Berman Group LLC | 1.08M |
RICE HALL JAMES & ASSOCIATES, LLC | 1.03M |
Perkins Investment Management, LLC | 0.85M |
Herald Investment Management Ltd | 0.82M |
Mirae Asset Global Investments Co., Ltd. | 0.79M |